← All investor calls
Sofinnova Partners
Series A: Metabolic & diabetes care
€5M–€15M · Series A · Apply by 5 Aug 2026 (GMT +1)
Investor calls are for startup accounts. Sign in or create a startup profile →
About this opportunity
Sofinnova Partners is actively investing in this space. Life sciences and digital medicine, seed to growth. We back founders with clinical evidence and a clear go-to-market.
- Investment stage
- Series A
- Typical ticket size
- €5M–€15M
Who should apply
- Therapeutic areas
- Metabolism and diabetes
- Service categories
- Glucose monitoringDisease management
- Geographic focus
- Does not matter
- Regions
- LATAMMiddle East
- Startup stage
- Scaling - ExpansionPre-launch - Concept or Prototype
- Maximum age
- 4 years
- Business model
- Health plans payHospitals payPublic pays (reimbursement)
Application questions
- What traction and clinical evidence do you have?
- What are you raising and on what terms?
- Why is now the right time for your company?
- If accepted
- Promising startups are invited to a first call with the investment team.